Biology Reference
In-Depth Information
Ratcliff, A., et al., 2007. Two fixed-dose artemisinin combinations for drug-resistant falci-
parum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Lancet 369, 757-765.
Reeve, P.A., et al., 1992. Acute intravascular haemolysis inVanuatu following a single dose of
primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. J. Trop.
Med. Hyg. 95 (5), 349-351.
Rijken, M.J., et al., 2011. Chloroquine resistant vivax malaria in a pregnant woman on the
western border of Thailand. Malar. J. 10 (1), 113.
Rodriguez, J.C., et al., 2011. Epidemiology and control of malaria in Colombia. Mem. Inst.
Oswaldo Cruz 106 (Suppl. 1), 114-122.
Rowland, M., Durrani, N., 1999. Randomized controlled trials of 5- and 14-days prima-
quine therapy against relapses of vivax malaria in an Afghan refugee settlement in Paki-
stan. Trans. R. Soc. Trop. Med. Hyg. 93 (6), 641-643.
Russell, B., et al., 2008. Determinants of in vitro drug susceptibility testing of
Plasmodium
vivax
. Antimicrob. Agents Chemother. 52 (3), 1040-1045.
Senn, N., et al., 2012. Intermittent preventive treatment for malaria in Papua New Guinean
infants exposed to
Plasmodium falciparum
and
P. vivax
: a randomized controlled trial. PLoS
Med. 9 (3), e1001195.
Silachamroon, U., et al., 2003. Clinical trial of oral artesunate with or without high-dose
primaquine for the treatment of vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 69
(1), 14-18.
Singh, R.K., 2000. Emergence of chloroquine-resistant vivax malaria in South Bihar (India).
Trans. R. Soc. Trop. Med. Hyg. 94, 327.
Sirichaisinthop, J., et al., 2011. Evaluation of loop-mediated isothermal amplification (LAMP)
for malaria diagnosis in a field setting. Am. J. Trop. Med. Hyg. 85 (4), 594-596.
Smithuis, F., et al., 2010. Effectiveness of five artemisinin combination regimens with or
without primaquine in uncomplicated falciparum malaria: an open-label randomised
trial. Lancet Infect. Dis. 10 (10), 673-681.
Steenkeste, N., et al., 2010. Sub-microscopic malaria cases and mixed malaria infection in a
remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication
for malaria elimination. Malar. J. 9 (1), 108.
Stepniewska, K., et al., 2008.
Plasmodium falciparum
gametocyte dynamics in areas of different
malaria endemicity. Malar. J. 7, 249.
Stohrer, J.M., et al., 2004. Therapeutic efficacy of artemether-lumefantrine and artesunate-
mefloquine for treatment of uncomplicated
Plasmodium falciparum
malaria in Luang
Namtha Province, Lao People's Democratic Republic. Trop. Med. Int. Health 9 (11),
1175-1183.
Sumawinata, I.W., et al., 2003. Very high risk of therapeutic failure with chloroquine for
uncomplicated
Plasmodium falciparum
and
P. vivax
malaria in Indonesian Papua. Am. J.
Trop. Med. Hyg. 68 (4), 416-420.
Sutanto, I., et al., 2009. Resistance to chloroquine by
Plasmodium vivax
at Alor in the Lesser
Sundas Archipelago in Eastern Indonesia. Am. J. Trop. Med. Hyg. 81 (2), 338-342.
Takeuchi, R., et al., 2010. Directly-observed therapy (DOT) for the radical 14-day primaquine
treatment of
Plasmodium vivax
malaria on the Thai-Myanmar border. Malar. J. 9 (1), 308.
Tan, L.K.K., et al., 2008. Acute lung injury and other serious complications of
Plasmodium
vivax
malaria. Lancet Infect. Dis. 8, 449-454.
Tarning, J., et al., 2008. Population pharmacokinetics of piperaquine after two different treat-
ment regimens with dihydroartemisinin-piperaquine in patients with
Plasmodium falci-
parum
malaria in Thailand. Antimicrob. Agents Chemother. 52, 1052-1061.
Thapa, S., et al., 2007. Comparison of artemether-lumefantrine with sulfadoxine-pyrimeth-
amine for the treatment of uncomplicated falciparum malaria in eastern Nepal. Am. J.
Trop. Med. Hyg. 77 (3), 423-430.
